Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Amylin”

91 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 91 results

Testing effectiveness (Phase 2)Study completedNCT00785408
What this trial is testing

Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects

Who this might be right for
ObesityOverweight
AstraZeneca 273
Large-scale testing (Phase 3)Study completedNCT00603239
What this trial is testing

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 165
Large-scale testing (Phase 3)Study completedNCT00641056
What this trial is testing

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 467
Not applicableUnknownNCT04243629
What this trial is testing

Co-administration of Pramlintide and Insulin Via an Automated Dual-hormone Artificial Pancreas System in Adults With Type 1 Diabetes

Who this might be right for
Diabetes Mellitus, Type 1Type 1 DiabetesPostprandial Hyperglycemia
McGill University 26
Not applicableNot Yet RecruitingNCT07340775
What this trial is testing

Hypersensitivity to Amylin in Post-Traumatic Headache

Who this might be right for
Headache Disorders, SecondaryBrain DiseasesHeadache Disorders+14 more
Danish Headache Center 21
Large-scale testing (Phase 3)Study completedNCT00381342
What this trial is testing

Safety and Efficacy of Exenatide as Monotherapy

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 233
Testing effectiveness (Phase 2)Study completedNCT00382239
What this trial is testing

Assess the Effect on Glucose Control and Safety and Tolerability of LY2148568 In Japanese Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 153
Not applicableStudy completedNCT00876213
What this trial is testing

Amylin and Glucagon-Like Peptide-1 (GLP-1): Influence on Gastric Emptying, Appetite and Food Intake in Humans

Who this might be right for
Diabetes
Hvidovre University Hospital 23
Large-scale testing (Phase 3)Study completedNCT01144338
What this trial is testing

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 14,752
Not applicableNot Yet RecruitingNCT06692088
What this trial is testing

"Longitudinal Analysis of Amylin Levels in Migraine Patients Undergoing an Anti- CGRP/CGRPr Treatment"

Who this might be right for
High Frequency Episodic Migraine and Chronic Migraine
Fundación Marques de Valdecilla 216
Large-scale testing (Phase 3)Study completedNCT00108004
What this trial is testing

Clinical Utility and Safety of Pramlintide in Subjects With Type 1 and Type 2 Diabetes Mellitus

Who this might be right for
Type 1 Diabetes MellitusType 2 Diabetes Mellitus
AstraZeneca 400
Large-scale testing (Phase 3)Study completedNCT00099320
What this trial is testing

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 182
Testing effectiveness (Phase 2)Study completedNCT00085969
What this trial is testing

Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
AstraZeneca 99
Large-scale testing (Phase 3)Study completedNCT00324363
What this trial is testing

Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Metformin or Sulfonylureas and Metformin

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 466
Large-scale testing (Phase 3)Study completedNCT00516074
What this trial is testing

Assess the Effect of Exenatide Treatment on Mean 24-Hour Heart Rate in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 54
Testing effectiveness (Phase 2)Study completedNCT00099333
What this trial is testing

Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 49
Large-scale testing (Phase 3)Study completedNCT00676338
What this trial is testing

Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

Who this might be right for
Type 2 Diabetes Mellitus
AstraZeneca 820
Testing effectiveness (Phase 2)Active Not RecruitingNCT06926842
What this trial is testing

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Who this might be right for
OverweightType 2 DiabetesObesity
Zealand Pharma 221
Testing effectiveness (Phase 2)Active Not RecruitingNCT06662539
What this trial is testing

Once-weekly Petrelintide Versus Placebo for Obesity or Overweight With Co-morbidities

Who this might be right for
Obesity
Zealand Pharma 493
Large-scale testing (Phase 3)Study completedNCT00360334
What this trial is testing

A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
AstraZeneca 235
Load More Results